Study Title | INTACT-TAA: A clinical trial of donor-derived WT1 specific T cells for prevention of relapse in combination with multiple pathogen specific T cells for prevention of infection in patients undergoing allogeneic haemopoietic stem cell transplant for acute myeloid leukaemia |
---|---|
Protocol ID | INTACT-TAA |
Disease (Sub Disease) | Acute Myelocytic Leukemia (AML) |
Diagnosis Stage | Relapse/ refractory |
Sponsor | University of Sydney |
Links | https://clinicaltrials.gov/ct2/show/NCT02895412 |
Trial Status | Closed to Recruitment |
Trial Open Date | 01/03/2017 |
Study Type | Treatment |
Phase | Phase 1 |
Age Eligibility | 1 Year to 70 Years |
International registry ID's | NCT02895412 |